Radcliffe Capital Management’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Radcliffe Capital Management’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,000	Closed	-$499K	–	977
2022 Q3	$499K	Hold	50,000	–	–	0.01%	1072
2022 Q2	$493K	Hold	50,000	–	–	0.01%	1131
2022 Q1	$492K	Hold	50,000	–	–	0.01%	1136
2021 Q4	$487K	Hold	50,000	–	–	0.01%	980
2021 Q3	$490K	Hold	50,000	–	–	0.01%	832
2021 Q2	$484K	Hold	50,000	–	–	0.02%	852
2021 Q1	$483K	Buy	+50,000	New	+$56.3K	0.02%	649

Other funds holding PKBOW

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Radcliffe Capital Management's PKBOW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Peak Bio, Inc. Warrant (PKBOW) in Q4 2022, closing a stake of 50,000 shares — an estimated $499K sold.

Radcliffe Capital Management first reported a position in PKBOW in Q1 2021 and held it in 7 quarters. The position peaked at $499K in Q3 2022. 15 funds tracked by Wall St. Rank hold PKBOW as of Q4 2022.

Radcliffe Capital Management reported no remaining Peak Bio, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 50,000 Peak Bio, Inc. Warrant shares in Q4 2022, an estimated $499K.
Radcliffe Capital Management first reported a position in Peak Bio, Inc. Warrant in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's Peak Bio, Inc. Warrant position peaked at $499K in Q3 2022.
15 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.